NCT04552158

Brief Summary

  1. 1.Assessment of nutritional status among patients with inflammatory bowel disease using different nutritional assessment tools.
  2. 2.Assessment of correlation between nutritional status and disease severity.
  3. 3.Assessment of the impact of the Mediterranean diet on the nutritional status of the patients after 3 months.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 17, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

July 21, 2021

Status Verified

September 1, 2020

Enrollment Period

1 month

First QC Date

September 6, 2020

Last Update Submit

July 19, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Assessment of nutritional status among patients with inflammatory bowel disease using body weight

    current body weight in kilograms will be measured

    Two time points: Change in body weight at patient presentation and after 3 months of medical management only

  • Assessment of nutritional status among patients with inflammatory bowel disease using body mass index (BMI)

    current body weight in kilograms and height in meters will be measured BMI is calculated in kg/m2

    Two time points: Change in BMI at patient presentation and after 3 months of medical management only

  • Assessment of nutritional status among patients with inflammatory bowel disease using the anthropometric measures

    triceps skin fold thickness (TST) in mm, mid arm circumference(MAC) in cm and mid arm muscle circumference in cm (MAMC) MAMC (cm) = MAC(cm) - { 0.314 X TST(mm) }.

    Two time points: Change in the anthropometric parameters at patient presentation and after 3 months of medical management only

  • Assessment of nutritional status among patients with inflammatory bowel disease using prognostic nutritional index (PNI)

    prognostic nutritional index (PNI) which is score derived from total lymphocytic count (TLC)and serum albumin (PNI = albumin g/dl x 10 + TLC/µL x 0.005)

    Two time points: Change in PNI score at patient presentation and after 3 months of medical management only

  • Assessment of nutritional status among patients with inflammatory bowel disease using controlling nutritional status(CONUT)

    controlling nutritional status (CONUT) is also a score derived from total lymphocytic count, serum albumin and blood cholesterol level

    Two time points: Change in CONUT score at patient presentation and after 3 months of medical management only

Secondary Outcomes (1)

  • Assessment of the impact of Mediterranean diet on the nutritional status for patients who received the Mediterranean diet after 3 months

    after 3 months of medical and Mediterranean diet management

Study Arms (2)

controlled group

NO INTERVENTION

patients with IBD who will be assessed for their nutritional status at day 0 and after 3 months of medical management only

experimental group

EXPERIMENTAL

patients with IBD who will be assessed for their nutritional status at day 0 and after 3 months of medical management and nutritional management in the form of the Mediterranean diet

Dietary Supplement: Mediterranean diet

Interventions

Mediterranean dietDIETARY_SUPPLEMENT

The Mediterranean diet (MedDiet) is a nutritional model inspired by the traditional dietary pattern of some of the countries of the Mediterranean basin. Mediterranean dietary pattern (MDP) gather the following characteristics: abundant consumption of olive oil and high consumption of fruits, vegetables, cereals (preferably as whole grain), legumes, nuts and seeds. The MDP also includes moderate consumption of fish and shellfish, white meat, eggs, and fermented dairy products (cheese and yogurt), as well as relatively small amounts of red meat, processed meats, and foods rich in sugars. Frequent but moderate intake of wine, especially red wine with meals is also recommended

experimental group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients with inflammatory bowel disease between 18 to 55 years

You may not qualify if:

  • presence of other diseases that affect the nutritional status of the patients like diabetes mellitus, liver cirrhosis, chronic kidney disease, and malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, Wu GD. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015 May;148(6):1087-106. doi: 10.1053/j.gastro.2015.01.007. Epub 2015 Jan 15.

    PMID: 25597840BACKGROUND
  • Lane ER, Zisman TL, Suskind DL. The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res. 2017 Jun 10;10:63-73. doi: 10.2147/JIR.S116088. eCollection 2017.

    PMID: 28652796BACKGROUND
  • Weber AT, Shah ND, Sauk J, Limketkai BN. Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence. Curr Treat Options Gastroenterol. 2019 Dec;17(4):564-576. doi: 10.1007/s11938-019-00248-z.

    PMID: 31705371BACKGROUND

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Yasmin A M Osman, assistant lecturer

CONTACT

Abeer Sh Abd Elrehim, Assistant professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: All Patients will be subjected to assessment of their nutritional status at day 0 and after 3 months of only medical management for the control group and of combined medical and nutritional management using Mediterranean dietary pattern for the experimental group
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

September 6, 2020

First Posted

September 17, 2020

Study Start

October 1, 2021

Primary Completion

November 1, 2021

Study Completion

December 1, 2022

Last Updated

July 21, 2021

Record last verified: 2020-09